Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Eloxx Pharmaceuticals Inc (ELOX)  
$0.81 0.02 (2.65%) as of 4:30 Fri 4/26


Download
   
Exchange: American Stock Exchange
Security Type: Common
Shares Out: 2,170,000
Market Cap: 1.75(M)
Last Volume: 881,740 Avg Vol: 301,084
52 Week Range: $0.62 - $10.9
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    AMEX COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical company developing an oral small molecule ribosome modulating agents and eukaryotic ribosome selective glycosides (ERSGs) for the treatment of rare and ultra-rare premature stop codon diseases and ribosomal mutations. Co.'s TURBO-ZM™ platform is designed to enable synthesis of macrolides that can be supported to modulate the human, bacterial or viral ribosomes to treat rare diseases. ELX-02, an ERSG, is a small molecule drug candidate designed as an analogue to gentamicin and geneticin to restore production of functional proteins, and is in clinical development for the treatment of cystic fibrosis patients with nonsense mutations.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-22 2023-11-21 2023-05-23 2022-05-23

   
Records found: 264
  Page 10 of 11  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Braca John N Director   –       •      –    2006-10-11 4 A $1.07 $10,700 D/D 10,000 18,000     -
   Galton Bruce C President & CEO   •       •      –    2006-10-11 4 A $1.07 $70,861 D/D 66,225 73,225     -
   Quick Thomas C Director   –       •      –    2006-10-11 4 A $1.07 $283,444 I/I 264,901 264,901     -
   Stalder Ruedi Director   –       •      –    2006-10-11 4 A $1.07 $100,000 D/D 93,458 201,771     -
   Forbes Christopher Director   –       •       •   2006-10-11 4 A $1.07 $944,812 D/D 883,002 1,532,571     -
   Rector David Director   –       •      –    2006-10-11 4 A $1.07 $10,700 D/D 10,000 21,000     -
   Forbes Christopher Director   –       •      –    2006-03-17 4 B $1.50 $60,000 D/D 40,000 649,569 2.39     -
   Stalder Ruedi officerTitle   –       •      –    2005-12-13 4 B $1.40 $14,000 D/D 10,000 108,313 2.39     -
   Braca John N Director   –       •      –    2005-11-28 4 B $1.59 $7,950 D/D 5,000 8,000 2.39     -
   Forbes Christopher Director   –       •      –    2005-11-28 4 B $1.49 $44,700 D/D 30,000 609,569 2.39     -
   Rector David Director   –       •      –    2005-11-22 4 B $1.31 $1,310 D/D 1,000 11,000 2.31     -
   Rector David Director   –       •      –    2005-11-21 4 B $1.27 $3,920 D/D 3,000 10,000 2.31     -
   Rector David Director   –       •      –    2005-06-08 4 B $2.24 $4,480 D/D 2,000 54,500 2.31     -
   Galton Bruce C President & CEO   •       •      –    2005-05-19 4/A B $2.25 $7,875 D/D 3,500 7,000 2.81     -
   Brooks Joel CFO and Treasurer   •       –      –    2005-05-19 4/A A $2.26 $4,520 D/D 2,000 4,000     -
   Rector David Director   –       •      –    2005-05-19 4 B $2.22 $6,660 D/D 3,000 52,500 2.39     -
   Galton Bruce C President & CEO   •       •      –    2005-05-19 4 B $2.25 $7,875 D/D 3,500 502,000 2.81     -
   Brooks Joel CFO and Treasurer   •       –      –    2005-05-19 4 B $2.26 $4,520 D/D 2,000 82,335 2.66     -
   Braca John N Director   –       •      –    2005-05-19 4 B $2.19 $6,570 D/D 3,000 20,500 2.39     -
   Rector David Director   –       •      –    2005-02-24 4 B $2.94 $5,880 D/D 2,000 2,000 2.39     -
   Stalder Ruedi Director   –       •      –    2004-01-23 4 B $0.00 $0 D/D 31,646 98,313 2.31     -
   Forbes Christopher Director   –       •      –    2004-01-23 4 B $0.00 $0 D/D 31,646 579,569 2.31     -
   Galton Bruce C President/Chief Exec Officer   •       •      –    2003-12-02 4 B $2.95 $4,475 D/D 1,500 3,500 2.73     -
   Seneca Capital Advisors Llc 10% Owner   –       –       •   2003-07-31 4 S $2.18 $436,000 I/I (200,000) 1,219,743     -
   Seneca Capital Advisors Llc 10% Owner   –       –       •   2003-06-24 5 S $2.05 $22,140 I/I (10,800) 1,419,743     -
  264 Records found
  Previous  10  11   
  Page 10 of 11
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us